Elanco Animal Health
ELAN | NYSE
$22.99
+$0.56 (+2.50%)
Sep 22, 2026, 1:01 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 530M | 428M | 545M | 505M | 539M | 487M | 468M | 490M | 416M | 345M | 352M | 369M | 367M | 318M | 345M | 460M | 507M | 342M | 638M | 453M | 580M | 515M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 14M | n/a | n/a | n/a | 33M | n/a | n/a | n/a | 87M | 33M | n/a | 43M | 35M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 304M | 295M | 304M | 306M | 294M | 312M | 311M | 302M | -3.71B | 346M | 341M | 410M | 419M | 369M | 378M | 376M | 376M | 559M | 390M | 357M | 375M | 325M |
Receivables | 1.15B | 1.15B | 940M | 975M | 1.1B | 1.06B | 886M | 904M | 1.08B | 1.08B | 1.01B | 1.14B | 1.23B | 1.26B | 1B | 1.03B | 1.13B | 1.19B | 1.03B | 1.08B | 1.17B | 1.13B |
Inventory | 1.77B | 1.72B | 1.74B | 1.71B | 1.67B | 1.59B | 1.57B | 1.63B | 1.61B | 1.64B | 1.74B | 1.69B | 1.69B | 1.6B | 1.54B | 1.34B | 1.33B | 1.35B | 1.37B | 1.38B | 1.45B | 1.42B |
Other Current Assets | n/a | 285M | 236M | 305M | 302M | 301M | 287M | 340M | 904M | 989M | 310M | 371M | 370M | 370M | 394M | 326M | 338M | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 3.8B | 3.58B | 3.46B | 3.49B | 3.61B | 3.44B | 3.22B | 3.37B | 4.01B | 4.05B | 3.41B | 3.57B | 3.65B | 3.55B | 3.28B | 3.15B | 3.31B | 3.19B | 3.27B | 3.16B | 3.43B | 3.34B |
Property-Plant & Equipment | 1.41B | 1.4B | 1.41B | 1.39B | 1.36B | 1.05B | 993M | 979M | 949M | 949M | 1.03B | 992M | 1.01B | 1B | 999M | 936M | 961M | 987M | 1.06B | 1.04B | 1.03B | 1.27B |
Goodwill & Intangibles | 8.05B | 7.95B | 8.19B | 8.36B | 8.46B | 8.14B | 8.1B | 8.64B | 8.48B | 8.67B | 9.59B | 9.38B | 10.72B | 10.85B | 10.84B | 10.48B | 10.96B | 11.51B | 11.76B | 12.01B | 11.99B | 12.05B |
Total Long-Term Assets | 9.76B | 9.64B | 9.9B | 10.06B | 10.13B | 9.5B | 9.4B | 9.92B | 9.75B | 9.97B | 10.96B | 10.78B | 12.14B | 12.22B | 12.21B | 11.79B | 12.29B | 13.06B | 13.2B | 13.41B | 13.4B | 13.64B |
Total Assets | 13.56B | 13.22B | 13.36B | 13.55B | 13.74B | 12.94B | 12.61B | 13.28B | 13.76B | 14.02B | 14.36B | 14.34B | 15.8B | 15.77B | 15.49B | 14.95B | 15.6B | 16.25B | 16.48B | 16.57B | 16.83B | 16.99B |
Account Payables | 427M | 372M | 368M | 352M | 368M | 330M | 296M | 259M | 291M | 302M | 270M | 296M | 354M | 381M | 390M | 350M | 386M | 402M | 416M | 436M | 506M | 411M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 73M | 73M | 74M | 62M | 61M | 44M | 44M | 44M | 213M | 38M | 38M | 39M | 39M | 381M | 388M | 394M | 56M | 61M | 294M | 61M | 555M | 605M |
Other Current Liabilities | n/a | 1.22B | 1.16B | 1.04B | 596M | 895M | 975M | 1.02B | 510M | 892M | 933M | 930M | 891M | 816M | 924M | 869M | 896M | 844M | 937M | 865M | 929M | 1.02B |
Total Current Liabilities | 1.85B | 1.66B | 1.6B | 1.46B | 1.39B | 1.27B | 1.32B | 1.32B | 1.37B | 1.23B | 1.24B | 1.27B | 1.28B | 1.58B | 1.7B | 1.61B | 1.34B | 1.31B | 1.65B | 1.36B | 1.99B | 2.03B |
Long-Term Debt | 3.85B | 3.92B | 3.94B | 3.96B | 4.15B | 4.35B | 4.28B | 4.31B | 5.46B | 5.73B | 5.74B | 5.87B | 6.02B | 5.64B | 5.45B | 5.51B | 6.01B | 6.07B | 6.03B | 6.27B | 5.54B | 5.56B |
Other Long-Term Liabilities | 551M | 776M | 889M | 907M | 931M | 487M | 477M | 587M | 465M | 474M | 595M | 432M | 411M | 409M | 390M | 465M | 496M | 512M | 533M | 522M | 554M | 563M |
Total Long-Term Liabilities | 5.12B | 5.06B | 5.21B | 5.35B | 5.58B | 5.32B | 5.2B | 5.44B | 6.45B | 6.73B | 6.9B | 6.95B | 7.09B | 6.71B | 6.5B | 6.59B | 7.12B | 7.33B | 7.32B | 7.52B | 6.86B | 6.95B |
Total Liabilities | 6.97B | 6.72B | 6.81B | 6.8B | 6.97B | 6.59B | 6.52B | 6.76B | 7.82B | 7.96B | 8.14B | 8.21B | 8.38B | 8.29B | 8.2B | 8.2B | 8.46B | 8.64B | 8.97B | 8.88B | 8.85B | 8.98B |
Total Debt | 3.92B | 3.99B | 4.02B | 4.02B | 4.21B | 4.4B | 4.32B | 4.36B | 5.68B | 5.77B | 5.77B | 5.91B | 6.06B | 6.02B | 5.84B | 5.9B | 6.06B | 6.13B | 6.32B | 6.33B | 6.1B | 6.16B |
Book Value | 6.59B | 6.5B | 6.55B | 6.75B | 6.78B | 6.35B | 6.1B | 6.52B | 5.94B | 6.06B | 6.22B | 6.13B | 7.42B | 7.48B | 7.29B | 6.75B | 7.14B | 7.61B | 7.51B | 7.68B | 7.98B | 8.01B |
Book Value Per Share | 13.02 | 12.85 | 13.18 | 13.58 | 13.55 | 12.73 | 12.33 | 13.11 | 12.02 | 12.21 | 12.63 | 12.45 | 15.06 | 15.18 | 14.92 | 13.81 | 14.62 | 15.47 | 15.40 | 15.76 | 16.38 | 16.45 |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -2.07B | -2.13B | -2.18B | -1.91B | -1.87B | -1.88B | -1.95B | -1.94B | -2.31B | -2.26B | -2.29B | -2.15B | -1.05B | -954M | -1.06B | -972M | -923M | -901M | -979M | -852M | -748M | -538M |
Comprehensive Income | -219M | -233M | -141M | -199M | -192M | -583M | -771M | -339M | -542M | -465M | -266M | -482M | -281M | -310M | -392M | -1.01B | -649M | -186M | -209M | -146M | 65M | -102M |
Shareholders Equity | 6.59B | 6.5B | 6.55B | 6.75B | 6.78B | 6.35B | 6.1B | 6.52B | 5.94B | 6.06B | 6.22B | 6.13B | 7.42B | 7.48B | 7.29B | 6.75B | 7.14B | 7.61B | 7.51B | 7.68B | 7.98B | 8.01B |
Total Investments | n/a | n/a | n/a | n/a | 14M | n/a | n/a | n/a | 33M | n/a | n/a | n/a | 87M | 33M | n/a | 43M | 35M | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ELAN